drugset / Trial / NCT06329492
Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the effectiveness and safety of autologous alpha-2 macroglobulin rich plasma (A2MRP) injections in the treatment of knee osteoarthritis (OA).
Timeline
- Start
- 2024-01-09
- Primary completion
- 2026-01-28
- Completion
- 2026-02-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | A2MRP | Unknown | — | Other |